Methyl isocyanate (MIC) is a toxic industrial chemical that is documented as a potent respiratory toxicant. We investigated cell-mediated immunity (CMI) in the MIC-exposed long-term survivors and their offspring born after the Bhopal gas-leak tragedy in 1984. Several earlier reports show inconsistency in the assessment of immunological effects of MIC on the human population. In these studies, important factors including lifestyle attributes were overlooked. We incorporated these factors also in our study of the basic cell-mediated immune function in the Bhopal MIC-affected population. Twenty-seven years after exposure, we assessed the circulating T-lymphocyte frequency using E-Rosette assay. A total of 46 MIC-exposed healthy long-term survivors and their offspring were studied vis-a-vis parallel gender–age group-matched unexposed controls from Bhopal and various other regions of India. The influence of several lifestyle variabilities (smoking, alcohol intake, and tobacco chewing) on T-lymphocyte frequency was also taken into consideration. Our observations suggest that Erythrocyte-Rosette-forming cell (E-RFC) distribution frequency is largely insignificant in the MIC-affected population as compared to controls (p > 0.05). In the MIC-affected tobacco chewers, there was a trend of suppression in CMI (relative decrease = 10.3%) as compared to nonchewers. Overall, our results show negligible long-term effect of MIC on CMI measured in terms of E-RFC frequency. These observations are not in agreement with earlier findings that immunosuppressive effects of MIC exposure persist in the T-cells of the affected population. However, atypical lymphocytes were frequently observed as E-RFC in the exposed females when compared to all other subgroups. Hematopoietic disorders (atypical lymphocytosis) in the MIC-affected population along with previous reports on the cytogenetic and humoral immune system linking cancer risk and chronic obstructive pulmonary disease (COPD) are important.
Agency for toxic substances and disease registry (ATSDR) (2002) Methyl Isocyanate (CAS#624-83-9): ToxFAQs™ — Emergency Department Management. Atlanta: United States Department of health and human services. Available at: http://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=629&tid=116 (accessed 8 June 2014).
2.
AiutiFCiarlaMVD’AseroC. (1973) Surface markers on lymphocytes of patients with infectious diseases. Infection and Immunity8: 110–117.
3.
AlexopoulosCBabitisP (1976) Age dependence of T lymphocytes. Lancet1: 426.
4.
ArinolaOGObisesanKSalimonuLS. (2004) Leucocyte phagocytosis and circulating immune complexes in mothers after child birth. West African Journal of Medicine23: 256–259.
5.
AugenerWCohenGReuterA. (1974) Decrease of T lymphocytes during ageing. Lancet1: 1164.
6.
BatesMNHamiltonJWLaKindJS. (2005) Workgroup report: biomonitoring study design, interpretation, and communication – lessons learned and path forward. Environmental Health Perspectives113: 1615–1621.
7.
BhargavaAPundeRPPathakN. (2010) Status of inflammatory biomarkers in the population that survived the Bhopal gas tragedy: a study after two decades. Industrial Health48: 204–208.
8.
BierJNicklischUPlatzH (1983) The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region. Cancer52: 1165–1172.
9.
BoldtDHArmstrongJP (1976) Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides. The Journal of Clinical Investigation57: 1068–1078.
BroheeDKennesBHubertC. (1980) Human lymphocyte affinity for sheep erythrocytes in young and aged healthy subjects. Clinical & Experimental Immunology42: 399–401.
12.
BroughtonE (2005) The Bhopal disaster and its aftermath: a review. Environmental Health4: 1–6.
13.
CarosellaEDMochankoKBraunM (1974) Rosette-forming T cells in human peripheral blood at different ages. Cellular Immunology12: 323–325.
14.
CheckIJHunterRLKarrisonT. (1981) Prognostic significance of immunological tests in lung cancer. Clinical & Experimental Immunology43: 362–369.
15.
Chemical Control Centre (CCC) (2008) Isocyanates: Laboratory Safety Bulletin. Windsor: University of Windsor. Available at: www.uwinsor.ca/ccc (accessed 27 March 2013).
16.
ChiewGSWengYC (1980) Aberrancies of human T- and B-lymphocyte populations in peripheral blood. Medical Journal of Malaysia34: 379–382.
17.
ClotJCharmassonEBrochierJ (1972) Age-dependent changes of human blood lymphocyte subpopulations. Clinical & Experimental Immunology32: 346–351.
18.
ColosioCBirindelliSCorsiniE. (2005) Low level exposure to chemicals and immune system. Toxicology and Applied Pharmacology207: S320–S328.
19.
DangDTPhamMHHoangTL. (1983) Rosette-forming cells in patients with treated leprosy. International Journal of Leprosy and Other Mycobacterial diseases51: 174–178.
20.
DeS (2012) Retrospective analysis of lung function abnormalities of Bhopal gas tragedy affected population. The Indian Journal of Medical Research135: 193.
21.
DeS (2013) Annual change in spirometric parameters among patients affected in Bhopal gas disaster: a retrospective observational study. Lung India30: 103.
22.
DeoMGGangalSBhiseyAN. (1987) Immunological, mutagenic and genotoxic investigations in gas exposed population of Bhopal. The Indian Journal of Medical Research86: 63–76.
23.
DharaVRDharaR (2002) The union carbide disaster in Bhopal: a review of health effects. Archives of Environmental Health57: 391–404.
24.
DonarhoeRMNicholsonJKAMaddenJJ. (1986) Coordinate and independent effects of heroin, cocaine and alcohol abuse on T-cell E-Rosette formation and antigenic marker expression. Clinical Immunology and Immunopathology41:254–264.
25.
DuramadPHollandNT (2011) Biomarkers of immunotoxicity for environmental and public health research. International Journal of Environmental Research and Public Health8: 1388–1401.
26.
FreshneyRI (1994) Culture of Animal Cells: A Manual of Basic Technique. 3rd ed. New York: Wiley-Liss.
27.
GoodRA (1972) Relations between immunity and malignancy. Proceedings of the National Academy of Sciences of the United States of America69: 1026.
28.
GrossRLLattyAWilliamsEA. (1975) Abnormal spontaneous rosette formation and rosette inhibition in lung carcinoma. The New England Journal of Medicine, 292: 439–443.
29.
HassanZMEbtekarMGhaneiM. (2006) Immunobiological consequences of sulfur mustard contamination. Iranian Journal of Allergy, Asthma, and Immunology5: 101–108.
30.
HicklingPTurnbullLDixonJS (1982) The relationship between disease activity, immunoglobulins and lymphocyte sub-populations in ankylosing spondylitis. Rheumatology and Rehabilitation21: 145–150.
31.
HookEB (1982) International commission for protection against environmental mutagens and carcinogens (ICPEMC) working paper 5/2: perspectives in mutation epidemiology: epidemiologic and design aspects of studies of somatic chromosome breakage and sister chromatid exchange. Mutation Research99: 373–382.
32.
Identifying & Controlling Immunotoxic Substances (ICIS) (1991) United States Congress, Office of Technology Assessment, Identifying & Controlling immunotoxic Substances-Background Paper, OTA-BP-BA-75. Washington: United States Government Printing Office (April 1991) (accessed 27 May 2010).
33.
Indian Council of Medical Research (ICMR) (2004) Health effects of the toxic gas leak from the union carbide Methyl isocyanate plant in Bhopal. Technical report on population-based long-term clinical studies (1985–1994). New Delhi: Indian Council of Medical Research. Available at: http://icmr.nic.in/pinstitute/nireh.htm (accessed 8 August 2012).
34.
Indian Council of Medical Research (ICMR) (2006) Ethical guidelines for biomedical research on human participants. Indian Council of Medical Research. New Delhi: Indian Council of Medical Research. Available at: http://icmr.nic.in/ethical_guidelines.pdf (accessed on 3 November 2008 and 18 February 2010).
35.
International Agency for Research on Cancer (IARC) (1999a) Toluene diisocyanates. In: Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 71. Part 2. pp. 865–879. Lyon: IARC. Available at: http://monographs.iarc.fr/ENG/Monographs/vol71/mono71-37.pdf (accessed 8 June 2014).
36.
International Agency for Research on Cancer (IARC) (1999b) 4,4′-Methylenediphenyl diisocyanate and polymeric 4,4- methylene diphenyl diisocyanate. In: Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 71. Part 3. pp. 1049–1058. Lyon: IARC. Available at: http://monographs.iarc.fr/ENG/Monographs/vol71/mono71-47.pdf (accessed 8 June 2014).
37.
International Programme on Chemical Safety (IPCS) (1996) Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals. Environmental Health Criteria, Vol. 180. Geneva, Switzerland: World Health Organization (WHO).
38.
KarolMHTaskarSGangalS. (1987) The antibody response to methyl isocyanate: experimental and clinical findings. Environmental Health Perspectives72: 169–175.
39.
KirschIRAbdallahJMBertnessVL. (1994) Lymphocyte-specific genetic instability and cancer. Cold Spring Harbor Symposia on Quantitative Biology59: 287–295.
40.
LandriganPJWilcoxKRSilvaJ (1979) Cohort study of Michigan residents exposed to poly brominated biphenyls: epidemiologic and immunologic findings. Annals of the New York Academy of Sciences320: 284–294.
41.
LusterMIBlankJADeanJH (1987) Molecular and cellular basis of chemically induced immunotoxicity. Annual Review of Pharmacology and Toxicology27: 23–49.
42.
LusterMIMunsonAEThomasPT. (1988) Development of a testing battery to assess chemical induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice. Fundamental and Applied Toxicology10: 2–19.
43.
LusterMITuckerANGermolecDR. (1986) Immunotoxicity studies in mice exposed to methyl isocyanate. Toxicology and Applied Pharmacology86: 140–144.
44.
MallaTMSenthilkumarCSSharmaNC. (2011) Chromosome Instability among Bhopal gas tragedy survivors. American-Eurasian Journal of Toxicological Sciences3: 245–249.
45.
MicheliABronJ (1974) Studies on blood T and B lymphocytes in rheumatoid arthritis. Annals of the Rheumatic Diseases33: 435–436.
46.
MishraPKDabadghaoSModiGK. (2009) In utero exposure to methyl isocyanate in the Bhopal gas disaster: evidence of persisting hyperactivation of immune system two decades later. Occupational and Environmental Medicine66: 279.
47.
NakashimaKTakeshitaTMorimotoK (2002) Review of the occupational exposure to isocyanates: mechanisms of action. Environmental Health and Preventive Medicine7: 1–6.
48.
NathNBansalSGargRK. (1993) Importance of thymus derived rosette forming cells in pulmonary tuberculosis. Indian Journal of Tuberculosis40: 145–147.
49.
OrloffKGBatts-OsborneDKilgusT. (1998) Antibodies to toluene diisocyanate in an environmentally exposed population. Environmental Health Perspectives106: 665–666.
50.
PietersR (2007) Detection of autoimmunity by pharmaceuticals. Methods41: 112–117.
51.
QuanPCBurtinP (1978) E-rosette-forming cells at 29°C: an assay for the evaluation of the immune status of cancer patients. British Journal of Cancer38: 606–611.
52.
RamaniSSubhashiniAV (1992) T lymphocytes in breast tumors. Indian Journal of Physiology and Pharmacology36: 73–74.
53.
RytterMJHKolteLBriendA. (2014) The immune system in children with malnutrition–A systematic review. PLoS One9: 1–19.
54.
SaranathDMukhopadhyayaRRaoRS. (1985) Cell-mediated immune status in patients with squamous cell carcinoma of the oral cavity. Cancer56: 1062–1070.
55.
SarangiSZaidiTPalRK. (2010) Effects of exposure of parents to toxic gases in Bhopal on the offspring. American Journal of Industrial Medicine53: 836–841.
56.
SavageAMPritchardJAVDeeleyTJ. (1980) Immunological state of patients with carcinoma of the bronchus before and after radiotherapy. Thorax35: 500–505.
57.
SaxenaAKSinghKPNagleSL. (1988) Effect of exposure to toxic gas on the population of Bhopal: part IV- immunological and chromosomal studies. Indian Journal of Experimental Biology26: 173–176.
58.
SearsHFTondreauSCRosenbergSA (1978) Advantages of cryopreserved lymphocytes for sequential evaluation of human immune competence. II. Mixed lymphocyte cultures and mononuclear cell subpopulations. Journal of the National Cancer Institute61: 1011–1016.
59.
SenthilkumarCS (2012) Bhopal Methyl isocyanate-affected population and cancer susceptibility: where do we stand now?Asian Pacific Journal of Cancer Prevention13: 5323–5324.
60.
SenthilkumarCSAkhterSMallaTM. (2015) Increased micronucleus frequency in peripheral blood lymphocytes contributes to cancer risk in the methyl isocyanate-affected population of Bhopal. Asian Pacific Journal of Cancer Prevention16: 4409–4419.
61.
SenthilkumarCSMallaTMSahNK. (2013) Methyl isocyanate exposure and atypical lymphocytes. The International Journal of Occupational and Environmental Medicine4: 167–168.
62.
SenthilkumarCSSahNKGaneshN (2012) Methyl isocyanate and carcinogenesis: bridgeable gaps in scientific knowledge. Asian Pacific Journal of Cancer Prevention13: 2429–2435.
63.
SenthilkumarCSTahirMSahNK. (2011) Cancer morbidity among methyl isocyanate exposed long-term survivors and their offspring: a hospital-based five year descriptive study (2006–2011) and future directions to predict cancer risk in the affected population. Asian Pacific Journal of Cancer Prevention12: 3443–3452.
64.
SijobladRD (1988) Potential future requirements for immunotoxicity testing of pesticides. Toxicology and Industrial Health4: 391–394.
65.
SilkworthJBLooseLD (1981) Assessment of environmental contaminant-induced lymphocyte dysfunction. Environmental Health Perspectives39: 105–128.
66.
SilvermanNAPotvinCAlexanderJC. (1975) In vitro lymphocyte reactivity and T-cell levels in chronic cigarette smokers. Clinical & Experimental Immunology22: 285–292.
67.
SimonMW (2003) The atypical lymphocyte. International Pediatrics18: 20–22.
68.
Skopinska-RózewskaEMajewskiSBłaszczykM. (1988) Theophylline-resistant and theophylline-sensitive “active” and “total” E rosette-forming lymphocytes in patients with systemic scleroderma. The Journal of Investigative Dermatology90: 851–856.
69.
SmithMAEvansJSteelCM (1974) Age-related variation in proportion of circulating T cells. Lancet304: 922–934.
70.
ToensPDStadlerWWullschlegeNJ (1998) In: WRC Report No. 839/1/98 The Association of Groundwater Chemistry and Geology with Atypical Lymphocytes (as Biological Indicator) in the Pofadder Area, North Western Cape, South Africa. Pretoria, SA: Water Research Commission, pp 144.
71.
VandenplasODelwicheJPStaquetP. (1999) Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects. The European Respiratory Journal13: 1144–1150.
72.
VarmaDRGuestI (1993) The Bhopal accident and methyl isocyanate toxicity. Journal of Toxicology and Environmental Health40: 513–529.
73.
WagnerMMFCampbellMJEdwardsRE (1979) Sequential immunological studies on an asbestos exposed population. I. Factors affecting peripheral blood leucocytes and T lymphocytes. Clinical & Experimental Immunology38: 323–331.
74.
WellsRAPavanandKZolyomiS. (1977) T lymphocyte Subpopulations in Thai Malaria Patients. In: The Annual Progress Report, Malaria studies. Bangkok: The Armed Forces Research Institute of Medical Sciences (AFRIMS). Available at: www.afrims.org/weblib/eapr/1977/APR77p163-165.pdf (accessed 2 April 2013).
75.
WhiteheadRHRobertsGPHughesLE. (1978) Importance of methodology in demonstrating depression of T-lymphocyte levels. British Journal of Cancer37: 28–32.
76.
WisnewskiAVLiuQLiuJ. (2008) Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI–albumin conjugates. Clinical and Experimental Allergy38: 957–967.
77.
WisnewskiAVStoweMHNerlingerA. (2012) Biomonitoring hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-Specific IgG. The Annals of Occupational Hygiene56: 901–910.
78.
World Health Organization (WHO) (1996) Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals. The International Programme on Chemical Safety (IPCS) Environmental Health Criteria, Vol. 180. Geneva, Switzerland: World Health Organization. Available at: http://www.inchem.org/documents/ehc/ehc/ehc180.htm (accessed 18 July 2013).
79.
World Health Organization/International Agency for Research on Cancer (WHO/IARC) Workshop’s Special Technical Report (1974) Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. London: Report of a WHO/IARC-Sponsored Workshop on Human B and T Cells (15–17 July 1974). Scand J Immunol3: 521–532.
80.
World Medical Association (WMA) (2000) Declaration of Helsinki (DoH) [Web page on the Internet]. Available at: http://www.wma.net/ (accessed 7 June 2007 and 18 February 2010).
81.
WybranJFudenbergHH (1973) Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. The Journal of Clinical Investigation52: 1026–1032.
82.
ZandiehTMarzbanSHassiriG. (1990) Evaluation of cell-mediated immunity in mustard gas injuries. Medical Journal of the Islamic Republic of Iran4: 257–260.
